NASDAQ:LUNG - Nasdaq - US7458481014 - Common Stock - Currency: USD
TTM (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
---|---|---|---|---|---|---|---|---|
Revenue | 79.30M | 68.67M | 53.66M | 48.42M | 32.73M | |||
Cost Of Goods | 20.49M | 17.92M | 13.80M | 12.79M | 11.53M | |||
Gross Profit | 58.81M | 50.75M | 39.87M | 35.63M | 21.20M | |||
Operating Expenses | 115.32M | 112.69M | 98.50M | 82.93M | 53.54M | |||
Research and Development | 15.77M | 18.08M | 15.40M | 13.06M | 7.46M | |||
Selling, General, and Administrative Expenses | 99.55M | 94.61M | 83.11M | 69.87M | 46.07M | |||
Operating Income | -56.51M | -61.94M | -58.64M | -47.30M | -32.33M | |||
Interest Income/Expense | 1.49M | 1.54M | 60.00K | -1.03M | -2.87M | |||
Other Income/Expense | 321.50K | 127.00K | 0.00 | 20.00K | 3.18M | |||
Income Before Taxes | -56.40M | -60.27M | -58.57M | -48.32M | -32.02M | |||
Income Tax | 710.00K | 571.00K | 350.00K | 340.00K | 210.00K | |||
Net Income | -57.11M | -60.84M | -58.92M | -48.66M | -32.23M | |||
EBITDA | -55.02M | -60.39M | -57.13M | -46.43M | -31.85M | |||
Per Share Data | ||||||||
EPS Diluted Total Ops | -1.47 | -1.60 | -1.59 | -1.35 | -0.90 | |||
Non GAAP EPS | -1.43 | -1.60 | -1.59 | -1.31 | N/A | |||
Statistics | ||||||||
Gross Profit Margin | 74.16% | 73.90% | 74.30% | 73.59% | 64.77% | |||
Profit Margin | -72.01% | -88.60% | -109.80% | -100.50% | -98.47% | |||
Operating Profit Margin | -71.25% | -90.19% | -109.28% | -97.69% | -98.78% |
All data in USD